Utilisation and optimisation of beta-adrenergic receptor blockers over a 6-month period among chronic heart failure patients with reduced ejection fraction
CONCLUSION: This study showed that 95.0% of chronic HF patients were utilising EBBBs, and none received the optimal dose as recommended in the guidelines. Pharmacotherapy with EBBBs should be optimised among patients with chronic HfrEF, as these drugs reduce both morbidity and mortality.PMID:37882131 | DOI:10.7196/SAMJ.2023.v113i9.784 (Source: South African Medical Journal)
Source: South African Medical Journal - October 26, 2023 Category: African Health Authors: M Kampamba P Mweetwa W Mufwambi A Hamachila J Hangoma Source Type: research
